Aug 07, 2019
Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody
Aug 06, 2019
Aevi Genomic Medicine to Present at the 2019 Wedbush PacGrow Healthcare Conference
Jul 15, 2019
Aevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Generation mTORC1/2 Inhibitor
Jan 02, 2019
Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD
Nov 26, 2018
Aevi Genomic Medicine to Host KOL Breakfast to Discuss Diagnosis and Treatment Paradigms in ADHD
Nov 01, 2018
Aevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business Update
Oct 15, 2018
Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial
Aug 21, 2018
Aevi Genomic Medicine Announces Capital Raise of $4.9M to Accelerate Part B of the ASCEND Trial
Jul 19, 2018
Aevi Genomic Medicine, Inc. Announces Novel Co-crystal Version of AEVI-001
Jun 13, 2018
Aevi Genomic Medicine to Present at the The 2018 JMP Securities Life Sciences Conference
Jun 12, 2018
Aevi Genomic Medicine Provides Update on Sample Size Re-estimation for Phase 2 ASCEND Trial in ADHD
May 29, 2018
Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference
May 15, 2018
Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update
Mar 20, 2018
Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference
Mar 13, 2018
Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Mar 07, 2018
Aevi Genomic Medicine Expands Collaboration with Kyowa Hakko Kirin
Mar 06, 2018
Aevi Genomic Medicine to Host Conference Call to Announce Fourth Quarter and Year End 2017 Financial Results
Dec 04, 2017
Aevi Genomic Medicine Announces New Appointment to its Board of Directors
Nov 02, 2017
Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results
Oct 17, 2017
Aevi Genomic Medicine Announces Completion of $28 Million Private Placement